XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk

Carcinogenesis

Volumn 28, Issue 6, 2007, Pages 1254-1258

  Liu, Geoffrey ^a,b,c   Zhou, Wei ^b   Yeap, Beow Y ^a   Su, Li ^b   Wain, John C ^a   Poneros, John M ^d   Nishioka, Norman S ^a   Lynch, Thomas J ^a   Christiani, David C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; ASPARTIC ACID; GENOMIC DNA; GLUTAMINE; LYSINE; ONCOPROTEIN; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BODY MASS; CANCER RISK; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; DNA REPAIR; ESOPHAGEAL ADENOCARCINOMA; EXCISION REPAIR; FEMALE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SMOKING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA REPAIR; DNA-BINDING PROTEINS; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 34447311097     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm020     Document Type: Article

References (41)

1. Ilson,D.H. (2003) Oesophageal cancer: New developments in systemic therapy. Cancer Treat. Rev., 29, 525-532.
2. Devesa,S.S., Blot,W.J. et al. (1988) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer, 83, 2049-2053.
3. Younes,M. et al. (2002) Incidence and survival trends of esophageal carcinoma in the United States: Racial and gender differences by histological type. Scand. J. Gastroenterol., 37, 1359-1365.
4. Katzka,D.A. et al. (2000) Gastroesophageal reflux disease and Barrett's esophagus. Med. Clin. North Am., 84, 1137-1161.
5. Cameron,A.J. (1997) Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol. Clin. North Am., 26, 487-494.
6. Sharma,P. et al. (1997) Dysplasia in short-segment Barrett's esophagus: A prospective 3-year follow-up. Am J. Gastroenterol., 92, 2012-2016.
7. Drewitz,D.J., Sampliner,R.E. et al. (1997) The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am. J. Gastroenterol., 92, 212-215.
8. Naidoo,R. et al. (1999) DNA repair gene status in oesophageal cancer. Mol. Pathol., 52, 125-130.
9. Casson,A.G. et al. (2005) Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis, 26, 1536-1541.
10. Wei,Q. et al. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study. J. Natl Cancer Inst., 92, 1764-1772.
11. Spitz,M.R. et al. (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res., 61, 1354-1357.
12. Shen,H. et al. (2003) DNA repair capacity and risk of nonsmall cell lung cancer. Int. J. Cancer, 107, 84-88.
13. Shi,Q. et al. (2004) Reduced DNA repair of benzo(a)pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis, 13, 1081-1083.
14. Ramos,J.M. et al. (2004) DNA repair and breast carcinoma susceptibility in women. Cancer, 100, 1352-1357.
15. Wei,Q. et al. (2003) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J. Natl Cancer Inst., 95 308-315.
16. Hu,J.J. et al. (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res., 64 1197-1201.
17. Thompson,L.H. et al. (2000) XRCC1 keeps DNA from getting stranded. Mutat. Res., 459, 1-18.
18. Benhamou,S. et al. (2002) XPD/XPD gene polymorphisms and cancer risk. Mutagenesis, 17, 463-469.
19. Lunn,R.M. et al. (1999) XRCC1 polymorphisms: Effects on allatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res., 59, 2557-2561.
20. Abdel-Rahman,S.Z. et al. (2000) The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett., 159, 63-71.
21. Duell,E.J. et al. (2000) Polymorphisms in the DNA repair genes XRCC1 and XPD and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 21, 965-971.
22. Hu,J.J. et al. (2001) Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis, 22, 917-922.
23. Palli,D. et al. (2001) DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer, 94, 121-127.
24. Qiao,Y. et al. (2002) Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ ERCC2 genotypes. Carcinogenesis, 23, 295-299.
25. Wang,Y. et al. (2003) From genotype to phenotype: Correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair, 2 901-908.
26. Lee,J.M. et al. (2001) Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int. J. Cancer, 95, 240-246.
27. Abdel-Rahman,S.Z. et al. (2000) Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett., 159, 79-86.
28. Shen,H. et al. (2000) Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int. J. Cancer 88, 601-606.
29. Ye,W. et al. (2006) The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: A population-based case-control study in Sweden. Carcinogenesis, 27, 1835-1841.
30. Miller,D.P. et al. (2002) Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res., 62, 2819-2823.
31. Zhou,W. et al. (2002) Gene-environment interaction for the XPD polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res., 62, 1377-1381.
32. Zhou,W. et al. (2003) Polymorphisms in the DNA repair genes XRCC1 and XPD, smoking, and lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 12, 359-365.
33. de las Penas,R. et al. (2006) Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann. Oncol., 17, 668-675.
34. Hosmer,D. et al. (1989) Applied Logistic Regression. John Wiley and Sons, New York.
35. Xing,D. et al. (2002) Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int. J. Cancer, 100, 600-605.
36. Shao,L. et al. (2006) Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer. Mutat. Res., 602, 143-150.
37. Cai,L. et al. (2006) Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer, 106, 2345-2354.
38. Hao,B. et al. (2004) Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res., 64, 4378-4384.
39. Goode,E.L. et al. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1513-1530.
40. Squire,J.A. et al. (1998) Genetic basis of cancer. In Hill,R.P. and Tannock,I.F. (eds.) The Basic Science of Oncology. McGraw-Hill Professional, NY, pp. 48-78.
41. Lunn,R.M. et al. (2000) XPD polymorphisms: Effects on DNA repair proficiency. Carcinogenesis, 21, 551-555.